Verdict: Side-by-side breakdown using the Bull Rankings model. ADUS scored 74.5, DVA scored 69.8 — ADUS leads.
Compare another set
ADUS
Addus HomeCare Corporation
Medical Care Facilities · Quality-Growth
74.5
$114.33 · $2.1B
fundamentals as of
Score gap
4.7
ADUS leads
DVA
DaVita Inc.
Medical Care Facilities · Quality-Growth
69.8
$179.25 · $11.4B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
CheapestDVA15.1x
Fastest growthADUS+23.2%
Highest qualityDVA86 / 100
Largest discount to fair valueDVA-62%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
ADUS
stronger →← stronger
DVA
59
Qualityreturns · margins · balance sheet
86
84
Growthrevenue & earnings expansion
68
84
Valuevaluation vs sector peers
58
ADUS is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
ADUS
DVA
$155mC
FCF
$1.6bC+
+23.2%A-
Rev
+6.4%C+
0.09B+
D/E
Negative equity
20.0xB+
P/E
15.1xA-
1.00B+
PEG
0.43A
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
ADUS
DVA
35% below
Price vs fair valuelower is cheaper
62% below
~-1%/yr
Growth the price impliesyr-1 FCF growth, fading to 4% · lower = less priced in
~-17%/yr
+35%
1-yr DCF upside
+155%
+53%
5-yr DCF upside
+164%
+83%
10-yr DCF upside
+178%
These two disagree on this pair: the Value pillar ranks cheapness against sector peers, while price-vs-fair-value is an absolute read. A name can be the better value in its sector and still the dearer one on cash flows.
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
ADUS
No notable signals flagged.
DVA
Why this score
Buying back stock
Durable high returns
The companies
ADUSAddus HomeCare Corporation
Medical Care Facilities · $114.33 · beta 0.83
Why now
Medical Care Facilities · market cap $2.1b. 8% off the 52-week high of $124.44. Revenue growing +23%, comfortably above the S&P median. 13 sell-side analysts rate this a Buy with a mean 1-yr target of $134.08 (implying +17% upside).
Moat
FCF converts 147% of net income — earnings translate cleanly into cash.
Risk
Mature compounder — the risk is paying up for quality at a moment when growth is decelerating. Watch for sequential revenue + margin trends; the inflection from "compounder" to "ex-compounder" is hard to spot until the multiple already started compressing.
DVADaVita Inc.
Medical Care Facilities · $179.25 · beta 0.80
Why now
Medical Care Facilities · market cap $11.4b. Down 28% from 52-week high of $247.49 — deep drawdown territory. PEG 0.43 — paying under fair value for the growth rate. 7 sell-side analysts rate this a Buy with a mean 1-yr target of $219.86 (implying +23% upside).
Moat
FCF converts 190% of net income — earnings translate cleanly into cash.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
Verdict — model-derived comparison
The model favors ADUS (74.7) over DVA (72) largely due to ADUS's superior Growth pillar score of 90, driven by its B+ revenue expansion of +15.9%. However, a contrarian could prefer DVA for its significant margin of safety, trading at a -66% discount to our DCF fair value and implying just -15% growth, alongside its "Buying back stock" signal.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where ADUS and DVA diverge
On the headline score the gap is 4.7 points in favor of ADUS. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
QualityADUS 59.1 · DVA 85.9DVA +26.8
ValueADUS 83.6 · DVA 58.4ADUS +25.2
GrowthADUS 83.6 · DVA 67.8ADUS +15.8
Pillars run 0–100. Value is judged against each company's own sector, so a Value score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.
Common questions
Is ADUS or DVA the better stock?
ADUS scores higher: ADUS 74.5, DVA 69.8 out of 100 on the Bull Rankings quality-growth score, which blends business quality, growth and valuation into one number. A higher score means a stronger business at a more reasonable price — it is not a price target or a recommendation.
Where do ADUS and DVA differ most?
The widest gap is quality, where DVA leads by 27 points on the 0–100 pillar scale. Neither name sweeps: they trade the lead across the three pillars, so the comparison is a trade-off rather than one being better on every measure.
How are ADUS and DVA scored?
Each carries the same 0–100 quality-growth score used everywhere on the site, built from three pillars — quality (profitability and returns on capital), growth (revenue and earnings), and value (what you pay for them) — combined as a geometric mean, so a weak pillar cannot be papered over by a strong one.
How current is this comparison?
The whole universe is re-scored every trading day after the US market close, so the scores and fundamentals here reflect the latest published edition.